Reuters – Eisai Co and Pfizer Inc said they won U.S. regulatory approval for a higher dose once-daily version of Aricept, a drug that treats Alzheimer disease.
View full post on Yahoo! News: Health News
Translator
Subscribe to the “Sleep Well Live Well” Blog by E-mail
